Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 USD | -5.75% | -8.12% | -24.07% |
05-14 | Earnings Flash (ALIM) ALIMERA SCIENCES Posts Q1 Revenue $23M, vs. Street Est of $22.3M | MT |
03-25 | Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.07% | 182M | |
-1.38% | 89.37B | |
+2.76% | 40.65B | |
-12.32% | 32.81B | |
+52.41% | 25B | |
-17.39% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- ALIM Stock
- News Alimera Sciences, Inc.
- Alliance Global Partners Downgrades Alimera Sciences to Neutral Rating From Buy, Adjusts Price Target to $4.50 From $11